APOLLOHOSP · Healthcare · Medical Care Facilities
Composite scorecard: 51/100 — Quality 38 · Valuation 37 · Growth 78 · Momentum 63
| Share price | ₹8,905.00 |
| Market cap | ₹1.12 lakh Cr |
| P/E ratio | 62.5 |
| P/B ratio | 12.4 |
| ROE | 36.0% |
| ROCE | 15.3% |
| Dividend yield | 0.26% |
| Book value | ₹632.45 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹25,228 Cr | ₹2,003 Cr | 15.0% |
| 2025 | ₹21,794 Cr | ₹1,505 Cr | 14.0% |
| 2024 | ₹19,059 Cr | ₹935 Cr | 13.0% |
| 2023 | ₹16,612 Cr | ₹844 Cr | 12.0% |
| 2022 | ₹14,663 Cr | ₹1,108 Cr | 15.0% |
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics, urology, organ transplantation, pulmonology, obstetrics and gynecology, internal medicine, vascular surgery, pediatrics, cosmetology, emergency medi